Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-09-27 | New | $200,155 | $200,155 | Other | 06b | SEC link |
| 2024-04-12 | New | $0 | $0 | Other | 06b | SEC link |
| 2024-04-12 | New | $1,750,000 | $1,750,000 | Equity Only | 06b | SEC link |
| 2024-04-12 | New | $1,240,737 | $1,240,737 | Equity Only | 06b | SEC link |
| 2020-09-16 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| 2020-08-11 | New | $8,000,000 | $8,000,000 | Debt Only | 06b | SEC link |
| 2020-07-15 | New | $4,000,000 | $4,000,000 | Equity Only | 06b | SEC link |
| 2020-02-03 | New | $7,474,986 | $7,474,986 | Equity Only | 06b | SEC link |
| 2019-08-14 | New | $13,799,915 | $13,799,915 | Equity Only | 06b | SEC link |
| 2017-07-07 | New | $6,000,000 | $6,000,000 | Equity Only | 06b | SEC link |
| 2005-05-09 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2005-05-09 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Chrystyna Bedrij Stecyk | Director |
| Alejandro M. Berlin | Director |
| Steven P. Cobourn | Executive |
| Alan L. Crane | Director |
| Elizabeth Evans | Executive |
| Jacob B. Frieberg | Director |
| Albert D. Friedberg | Director |
| J. Jeffrey Goater | Director |
| J. Jeffrey Goater | Director |
| John E. Leonard | Executive |
| Bala S. Manian | Director |
| Bala S. Manian Ph.D. | Director |
| Bala S. Manian, Ph.D. | Director |
| Scott E. Royer | Executive |
| Jill Sanchez | Executive |
| Ernest S. Smith | Executive |
| Ernest S. Smith Ph.D. | Executive |
| Ernest S. Smith, Ph.D. | Executive |
| Gerald E. Van Strydonck | Director |
| Raymond E. Watkins | Executive |
| Barbara Yanni | Director |
| Barbara Yannni | Director |
| Maurice Zauderer | Director, Executive |
| Maurice Zauderer, Ph.D. | Director, Executive |